Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | NL-201 |
Trade Name | |
Synonyms | NL201|NL 201 |
Drug Descriptions |
NL-201 is an agonist of the IL-2 and IL-15 receptors, with enhanced affinity for the beta and gamma subunits, which may stimulate natural killer and effector T cells, leading to an antitumor response (PMID: 37956421). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C176866 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
NL-201 | NL-201 | 0 | 1 |
NL-201 + Radiotherapy | NL-201 Radiotherapy | 0 | 0 |
NL-201 + Radiotherapy + unspecified PD-1 antibody | NL-201 Radiotherapy unspecified PD-1 antibody | 0 | 0 |